Parkinson's Disease Neuroprotection Clinical Trial
Scott, Burton L.
Duke University, Durham, NC, United States
See 16 grants from Burton Scott
See 30759 grants from Duke University
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
Effect of Apolipoprotein Structural Adaptability
Novel Probes for Studying Treatment of CNS-based Lysosomal Storage Diseases
Targeted Pharmacological Chaperones for Neurological Diseases
Enzyme replacement therapy for Sanfilippo A lysosomal rare disease
Gaucher disease:Treatment of neurodegenerative disease
Recently added grants:
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 Proteinopathies
Resilient versus fragile aspects of blood flow in the mammalian brain
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
Mechanisms of neurotransmitter release and its regulation
Mechanisms and Functions of Synapses and Circuits
National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Cooperative Clinical Research--Cooperative Agreements (U10)
Special Emphasis Panel (ZNS1-SRB-B (34))
Moy, Claudia S
Schools of Medicine
Mauldin, Patrick D; Guimaraes, Paulo; Albin, Roger L et al.
Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.
Clin Ther 30:1553-7
Be the first to comment on Burton Scott's grant
Share this grant: